Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,126.40
+5.10 (0.45%)
May 11, 2026, 3:29 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 138.2 billion as of May 11, 2026. Its market cap has increased by 14.03% in one year.
Market Cap
138.20B
Enterprise Value
132.28B
Revenue
25.12B
Ranking
n/a
PE Ratio
25.46
Stock Price
1,126.40
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 138.20B, an increase of 50.69%. That is a compound annual growth rate of 9.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 137.62B | 22.39% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 311.50B |
| Wockhardt | 261.04B |
| Piramal Pharma | 238.81B |
| NATCO Pharma | 210.40B |
| Eris Lifesciences | 192.03B |
| Cohance Lifesciences | 186.77B |
| Alembic Pharmaceuticals | 154.71B |
| Strides Pharma Science | 106.63B |